ATE164066T1 - Neue pharmazeutische formulierungen von 5-(2- chlor-1-hydroxyethyl)-4-methylthiazol - Google Patents
Neue pharmazeutische formulierungen von 5-(2- chlor-1-hydroxyethyl)-4-methylthiazolInfo
- Publication number
- ATE164066T1 ATE164066T1 AT91915138T AT91915138T ATE164066T1 AT E164066 T1 ATE164066 T1 AT E164066T1 AT 91915138 T AT91915138 T AT 91915138T AT 91915138 T AT91915138 T AT 91915138T AT E164066 T1 ATE164066 T1 AT E164066T1
- Authority
- AT
- Austria
- Prior art keywords
- methylthiazole
- hydroxyethyl
- pharmaceutical formulations
- chlorine
- new pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/24—Radicals substituted by oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9002659A SE9002659D0 (sv) | 1990-08-15 | 1990-08-15 | New pharmaceutical formulations |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE164066T1 true ATE164066T1 (de) | 1998-04-15 |
Family
ID=20380161
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT91915138T ATE164066T1 (de) | 1990-08-15 | 1991-08-07 | Neue pharmazeutische formulierungen von 5-(2- chlor-1-hydroxyethyl)-4-methylthiazol |
Country Status (26)
Country | Link |
---|---|
US (1) | US5385921A (de) |
EP (1) | EP0619734B1 (de) |
JP (1) | JP3094077B2 (de) |
AT (1) | ATE164066T1 (de) |
AU (1) | AU657490B2 (de) |
BG (1) | BG97446A (de) |
CA (1) | CA2088775A1 (de) |
CZ (1) | CZ279586B6 (de) |
DE (1) | DE69129126T2 (de) |
DK (1) | DK0619734T3 (de) |
ES (1) | ES2114891T3 (de) |
FI (1) | FI930608A (de) |
HU (1) | HUT65821A (de) |
IE (1) | IE912818A1 (de) |
IL (1) | IL99169A (de) |
IS (1) | IS3743A7 (de) |
LT (1) | LT3978B (de) |
LV (1) | LV10921B (de) |
NO (1) | NO303447B1 (de) |
NZ (1) | NZ239329A (de) |
PT (1) | PT98688B (de) |
RO (1) | RO112994B1 (de) |
RU (1) | RU2093155C1 (de) |
SE (1) | SE9002659D0 (de) |
SK (1) | SK8793A3 (de) |
WO (1) | WO1992003134A1 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9901658D0 (sv) * | 1999-05-06 | 1999-05-06 | Astra Ab | New formulation |
SE9904177D0 (sv) * | 1999-11-18 | 1999-11-18 | Astra Ab | Novel compounds |
US6699866B2 (en) | 2001-04-17 | 2004-03-02 | Sepracor Inc. | Thiazole and other heterocyclic ligands for mammalian dopamine, muscarinic and serotonin receptors and transporters, and methods of use thereof |
CN103772313B (zh) * | 2014-01-02 | 2015-10-14 | 郑桂富 | 一种4-甲基-5-(2-羟乙基)噻唑的合成方法 |
CN112262814A (zh) * | 2020-10-26 | 2021-01-26 | 宜宾学院 | 油樟叶渣发酵床养鸡方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2825966A1 (de) * | 1978-06-14 | 1980-01-03 | Basf Ag | Saures galvanisches nickelbad, das sulfobetaine als glanz- und einebnungsmittel enthaelt |
GB8600783D0 (en) * | 1986-01-14 | 1986-02-19 | Merck Sharp & Dohme | N-methyl-d-aspartate receptor antagonists |
-
1990
- 1990-08-15 SE SE9002659A patent/SE9002659D0/xx unknown
-
1991
- 1991-08-07 RO RO93-00194A patent/RO112994B1/ro unknown
- 1991-08-07 CZ CS93166A patent/CZ279586B6/cs unknown
- 1991-08-07 HU HU9300388A patent/HUT65821A/hu unknown
- 1991-08-07 JP JP03514007A patent/JP3094077B2/ja not_active Expired - Lifetime
- 1991-08-07 ES ES91915138T patent/ES2114891T3/es not_active Expired - Lifetime
- 1991-08-07 CA CA002088775A patent/CA2088775A1/en not_active Withdrawn
- 1991-08-07 DK DK91915138T patent/DK0619734T3/da active
- 1991-08-07 SK SK8793A patent/SK8793A3/sk unknown
- 1991-08-07 RU RU9193004984A patent/RU2093155C1/ru active
- 1991-08-07 WO PCT/SE1991/000522 patent/WO1992003134A1/en active IP Right Grant
- 1991-08-07 AT AT91915138T patent/ATE164066T1/de not_active IP Right Cessation
- 1991-08-07 DE DE69129126T patent/DE69129126T2/de not_active Expired - Lifetime
- 1991-08-07 AU AU84092/91A patent/AU657490B2/en not_active Ceased
- 1991-08-07 EP EP91915138A patent/EP0619734B1/de not_active Expired - Lifetime
- 1991-08-09 NZ NZ239329A patent/NZ239329A/en unknown
- 1991-08-09 IE IE281891A patent/IE912818A1/en unknown
- 1991-08-12 IL IL9916991A patent/IL99169A/en active IP Right Grant
- 1991-08-14 PT PT98688A patent/PT98688B/pt not_active IP Right Cessation
- 1991-08-14 US US07/744,914 patent/US5385921A/en not_active Expired - Lifetime
- 1991-08-14 IS IS3743A patent/IS3743A7/is unknown
-
1993
- 1993-02-09 NO NO930452A patent/NO303447B1/no not_active IP Right Cessation
- 1993-02-11 FI FI930608A patent/FI930608A/fi unknown
- 1993-02-15 BG BG97446A patent/BG97446A/xx unknown
- 1993-08-10 LV LVP-93-1024A patent/LV10921B/en unknown
- 1993-12-30 LT LTIP1714A patent/LT3978B/lt not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI913248A (fi) | Kontrollerat frigoerande fast farmaceutisk doseringsform. | |
FI933248A (fi) | Optiskt aktiva 5h-pyrrolo(3,4-b)pyrazinderat, dess framstaellning och farmaceutiska kompositioner innehaollande detta | |
MX9102473A (es) | Agentes farmaceuticos. | |
DK1155695T3 (da) | Anvendelse af en 1,3-oxathiolannukleosid-analog til fremstillingen af et lægemiddel til specifik indgivelse | |
DE69227407D1 (de) | Superlumineszierende optische Quelle | |
DK0535034T3 (da) | Farmaceutisk aktive benzoquinazolinforbindelser | |
GR920100570A (el) | Παραγωγα 3(2η)-πυριδαζινονης και μεθοδος για την παρασκευη τους. | |
DE69129126T2 (de) | Neue pharmazeutische formulierungen von 5-(2-chlor-1-hydroxyethyl)-4-methylthiazol | |
TR27833A (tr) | Antelmintik'lerin uygulanmasina mahsus ''pour-on'' formülasyonu. | |
DE69115528T2 (de) | Neue pharmazeutische Verwendungen von Forskolin-Derivaten | |
NO306381B1 (no) | Farmasöytisk ampulle | |
ATE138570T1 (de) | Neue verwendung von bambuterol | |
RU93004984A (ru) | Фармацевтическая композиция на основе 5(2-хлор-1-гидроксиэтил)-4-метилтиазола, применение 5-(2-хлор-1-гидроксиэтил)-4-метил-тиазола для лечения, способ лечения, соли 5-(2-хлор-1-гидроксиэтил)-4-метилтиазола | |
FI910773A0 (fi) | Farmaceutisk komposition innehaollande ett episialo-kolhydratkomplex. | |
FI930967A0 (fi) | Substituerade 6,7-dihydroimidazo(1,5,4-ef)(1,5)bensodiazepin-6-oner, deras framstaellning och farmaceutiska kompositioner | |
SE9000288D0 (sv) | New use | |
MX9203359A (es) | Nuevas composiciones farmaceuticas de insulina. | |
IT9022493A0 (it) | Composizione farmaceutica a rilascio controllato contenente un sale farmaceuticamente accettabile di buflomedil | |
KR920007598U (ko) | 의약용 캅셀 | |
ITMI911049A1 (it) | Composizione oftalmica | |
FI971316A0 (fi) | Farmaseuttinen yhdiste |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |